Article Information
History
- May 13, 2020.
Article Versions
- You are currently viewing Version 1 of this article (May 13, 2020 - 15:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapetuiques, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France
- 2Labex LERMIT, DHU TORINO, SIRIC SOCRATE
- 3Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France
- 4Department of vascular surgery, thoracic surgery, and lung transplantation, Bichat Hospital, Assistance Publique – Hôpitaux de Paris, INSERM U1152, Université de Paris, Paris, France
- ↵*Corresponding authors: Eric Deutsch and Lydia Meziani, Gustave Roussy, INSERM U1030, 114 rue Edouard Vaillant; 94805 Villejuif, France; eric.deutsch{at}gustaveroussy.fr, lydia.meziani{at}gustaveroussy.fr
Posted May 13, 2020.
Low doses of radiation therapy increase the immunosuppressive profile of lung macrophages via IL-10 production and IFNγ/IL-6 suppression: a therapeutic strategy to counteract lung inflammation?
